The Calmer Co International Limited (ASX:CCOR)

Market Cap	7.66M
Revenue (ttm)	7.20M
Net Income (ttm)	-4.45M
Shares Out	n/a
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,715
Average Volume	47,858
Open	0.0010
Previous Close	0.0030
Day's Range	0.0010 - 0.0010
52-Week Range	0.0010 - 0.0030
Beta	n/a
RSI	n/a
Earnings Date	May 29, 2025

About ASX:CCOR

The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, the United States, and internationally. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; cold pressed shots and kava under the Taki Mai brand name; hemp, CBD oils, topical products, and kava tinctures under Danodan brand name; and nutraceuticals. It also markets Leilo kava beverages. In addition, it sells its products through retailers and online. The company was formerly known as Fiji Kava Limited and...

• Industry: Pharmaceutical Preparations
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CCOR

Financial Performance

In 2024, ASX:CCOR's revenue was 4.26 million, an increase of 138.92% compared to the previous year's 1.78 million. Losses were -3.73 million, -30.37% less than in 2023.